Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2

Cancer Letters

Volumn 238, Issue 2, 2006, Pages 248-259

  Dihal, Ashwin A ^a,b   Woutersen, Ruud A ^a   Ommen, Ben van ^a   Rietjens, Ivonne M C M ^b   Stierum, Rob H ^a  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Caco 2; Colorectal cancer; Differentiation; Metabolism; Proliferation; Quercetin

Indexed keywords

3' O METHYLQUERCETIN 4' O GLUCURONIDE; 3' O METHYLQUERCETIN 7 O SULFATE; 4' O METHYLQUERCETIN 3' O GLUCURONIDE; 4' O METHYLQUERCETIN 7 O GLUCURONIDE; ISORHAMNETIN; QUERCETIN; QUERCETIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN CACO 2; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANTICARCINOGENIC AGENTS; CACO-2 CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DRUG STABILITY; HUMANS; QUERCETIN;

EID: 33744996041     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.07.007     Document Type: Article

References (53)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: globocan 2000. Int. J. Cancer 94 (2001) 153-156
2. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1 (2001) 55-67
3. Stierum R., Gaspari M., Dommels Y., Ouatas T., Pluk H., Jespersen S., Vogels J., Verhoeckx K., Groten J., and van Ommen B. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim. Biophys. Acta 1650 (2003) 73-91
4. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
5. Fodde R. The APC gene in colorectal cancer. Eur. J. Cancer 38 (2002) 867-871
6. Bingham S.A., Day N.E., Luben R., Ferrari P., Slimani N., Norat T., Clavel-Chapelon F., Kesse E., Nieters A., Boeing H., Tjonneland A., Overvad K., Martinez C., Dorronsoro M., Gonzalez C.A., Key T.J., Trichopoulou A., Naska A., Vineis P., Tumino R., Krogh V., Bueno-de-Mesquita H.B., Peeters P.H., Berglund G., Hallmans G., Lund E., Skeie G., Kaaks R., and Riboli E. European Prospective Investigation into Cancer and Nutrition, Dietary fibre in food and protection against colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC): an observational study. Lancet 361 (2003) 1496-1501
7. Knekt P., Jarvinen R., Seppanen R., Hellovaara M., Teppo L., Pukkala E., and Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 146 (1997) 223-230
8. Schoen R.E. The case for population-based screening for colorectal cancer. Nat. Rev. Cancer 2 (2002) 65-70
9. Manach C., Scalbert A., Morand C., Remesy C., and Jimenez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79 (2004) 727-747
10. Day A.J., DuPont M.S., Ridley S., Rhodes M., Rhodes M.J., Morgan M.R., and Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 436 (1998) 71-75
11. Kim D.H., Jung E.A., Sohng I.S., Han J.A., Kim T.H., and Han M.J. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 21 (1998) 17-23
12. Hollman P.C., de Vries J.H., van Leeuwen S.D., Mengelers M.J., and Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62 (1995) 1276-1282
13. Jones D.J., Lamb J.H., Verschoyle R.D., Howells L.M., Butterworth M., Lim C.K., Ferry D., Farmer P.B., and Gescher A.J. Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity. Br. J. Cancer 91 (2004) 1213-1219
14. Day A.J., Bao Y., Morgan M.R., and Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic. Biol. Med. 29 (2000) 1234-1243
15. Avila M.A., Velasco J.A., Cansado J., and Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 54 (1994) 2424-2428
16. Tanaka T., Kawabata K., Honjo S., Kohno H., Murakami M., Shimada R., Matsunaga K., Yamada Y., and Shimizu M. Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin. Oncol. Rep. 6 (1999) 1333-1340
17. Murota K., and Terao J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417 (2003) 12-17
18. Kuo S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110 (1996) 41-48
19. van der Woude H., Gliszczynska-Swiglo A., Struijs K., Smeets A., Alink G.M., and Rietjens I.M. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett. 200 (2003) 41-47
20. Delie F., and Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14 (1997) 221-286
21. Fleet J.C., Wang L., Vitek O., Craig B.A., and Edenberg H.J. Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation. Physiol. Genomics 13 (2003) 57-68
22. Souleimani A., and Asselin C. Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett. 326 (1993) 45-50
23. Murota K., Shimizu S., Chujo H., Moon J.H., and Terao J. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch. Biochem. Biophys. 384 (2000) 391-397
24. Wenzel U., Kuntz S., Brendel M.D., and Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 60 (2000) 3823-3831
25. Llor X., Pons E., Roca A., Alvarez M., Mane J., Fernandez-Banares F., and Gassull M.A. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin. Nutr. 22 (2003) 71-79
26. Dzierzewicz Z., Orchel A., Weglarz L., Latocha M., and Wilczok T. Changes in the cellular behaviour of human colonic cell line Caco-2 in response to butyrate treatment. Acta Biochim. Pol. 49 (2002) 211-220
27. Wachtershauser A., Akoglu B., and Stein J. HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2. Carcinogenesis 22 (2001) 1061-1067
28. Boersma M.G., van der Woude H., Bogaards J., Boeren S., Vervoort J., Cnubben N.H., van Iersel M.L., van Bladeren P.J., and Rietjens I.M. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol. 15 (2002) 662-670
29. Tietz N.W., Rinker A.D., and Shaw L.M. International federation of clinical chemistry. IFCC methods for the measurement of catalytic concentration of enzymes. Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). IFCC document stage 2, draft 1, 1983-03 with a view to an IFCC recommendation. Clin. Chim. Acta 135 (1983) 339F-367F
30. Masungi C., Borremans C., Willems B., Mensch J., van Dijck A., Augustijns P., Brewster M.E., and Noppe M. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds. J. Pharm. Sci. 93 (2004) 2507-2521
31. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
32. van der Woude H., Boersma M.G., Vervoort J., and Rietjens I.M. Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chem. Res. Toxicol. 17 (2004) 1520-1530
33. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., and Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342 (1993) 1007-1011
34. Weldin J., Jack R., Dugaw K., and Kapur R.P. Quercetin, an over-the-counter supplement, causes neuroblastoma-like elevation of plasma homovanillic acid. Pediatr. Dev. Pathol. 6 (2003) 547-551
35. Yu Z., Li W., and Liu F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett. 215 (2004) 159-166
36. Kuntz S., Wenzel U., and Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 38 (1999) 133-142
37. Lee K.W., Hur H.J., Lee H.J., and Lee C.Y. Antiproliferative effects of dietary phenolic substances and hydrogen peroxide. J. Agric. Food Chem. 53 (2005) 1990-1995
38. van Erk M.J., Roepman P., van der Lende T.R., Stierum R.H., Aarts J.M., van Bladeren P.J., and van Ommen B. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur. J. Nutr. 44 (2004) 143-156
39. Wenzel U., Herzog A., Kuntz S., and Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics 4 (2004) 2160-2174
40. Goodman J.E., Bowman E.D., Chanock S.J., Alberg A.J., and Harris C.C. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 25 (2004) 2467-2472
41. Murota K., Shimizu S., Miyamoto S., Izumi T., Obata A., Kikuchi M., and Terao J. Unique uptake and transport of isoflavone aglycones by human intestinal caco-2 cells: comparison of isoflavonoids and flavonoids. J. Nutr. 132 (2002) 1956-1961
42. Graefe E.U., Wittig J., Mueller S., Riethling A.K., Uehleke B., Drewelow B., Pforte H., Jacobasch G., Derendorf H., and Veit M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 41 (2001) 492-499
43. Qiu Y., Waters C.E., Lewis A.E., Langman M.J., and Eggo M.C. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J. Endocrinol. 174 (2002) 369-377
44. Campbell-Thompson M., Lynch I.J., and Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res. 61 (2001) 632-640
45. Chen A.C., and Donovan S.M. Genistein at a concentration present in soy infant formula inhibits Caco-2 BBe cell proliferation by causing G2/M cell cycle arrest. J. Nutr. 134 (2004) 1303-1308
46. Zava D.T., and Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer 27 (1997) 31-40
47. Maggiolini M., Bonofiglio D., Marsico S., Panno M.L., Cenni B., Picard D., and Ando S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 60 (2001) 595-602
48. Bjeldanes L.F., and Chang G.W. Mutagenic activity of quercetin and related compounds. Science 197 (1977) 577-578
49. Seino Y., Nagao M., Yahagi T., Sugimura T., Yasuda T., and Nishimura S. Identification of a mutagenic substance in a spice, sumac, as quercetin. Mutat. Res. 58 (1978) 225-229
50. Deschner E.E., Ruperto J., Wong G., and Newmark H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12 (1991) 1193-1196
51. Pereira M.A., Grubbs C.J., Barnes L.H., Li H., Olson G.R., Eto I., Juliana M., Whitaker L.M., Kelloff G.J., Steele V.E., and Lubet R.A. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17 (1996) 1305-1311
52. Pamukcu A.M., Yalciner S., Hatcher J.F., and Bryan G.T. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res. 40 (1980) 3468-3472
53. Yang K., Lamprecht S.A., Liu Y., Shinozaki H., Fan K., Leung D., Newmark H., Steele V.E., Kelloff G.J., and Lipkin M. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 21 (2000) 1655-1660